Phospholipase C isozymes are deregulated in colorectal cancer - insights gained from gene set enrichment analysis of the transcriptome

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Danielsen, Stine A ^a,b   Cekaite, Lina ^a,b   Ågesen, Trude H ^a,b   Sveen, Anita ^a,b   Nesbakken, Arild ^a,b   Thiis Evensen, Espen ^a   Skotheim, Rolf I ^a,b   Lind, Guro E ^a,b   Lothe, Ragnhild A ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; K RAS PROTEIN; MESSENGER RNA; PHOSPHOLIPASE C; PLCD1 PROTEIN; PLCE1 PROTEIN; PROTEIN P53; TRANSCRIPTOME; UNCLASSIFIED DRUG; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C DELTA; PHOSPHOLIPASE C EPSILON; PLCD1 PROTEIN, HUMAN;

ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REGULATORY NETWORK; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC MARKER; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR BIOPSY; COLORECTAL TUMOR; DNA METHYLATION; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE; TUMOR GENE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; ISOENZYMES; MUTATION; PHOSPHATIDYLINOSITOLS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PHOSPHOLIPASE C DELTA; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 80052353715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024419     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. O'Connell JB, Maggard MA, Ko CY, (2004) Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96: 1420-1425.
3. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. PNAS 104: 18654-18659.
4. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, et al. (2009) Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives. Cancer Treat Rev 35: 201-209.
5. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
6. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25: 25-29.
7. Kanehisa M, Goto S, (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28: 27-30.
8. Chalhoub N, Baker SJ, (2009) PTEN and the PI3-Kinase Pathway in Cancer. Annu Rev Pathol Mech Dis 4: 127-150.
9. Fukami K, Inanobe S, Kanemaru K, Nakamura Y, (2010) Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog Lipid Res 49: 429-437.
10. Fukami K, (2002) Structure, regulation, and function of phospholipase C isozymes. J Biochem 131: 293-299.
11. Sillars-Hardebol AH, Carvalho B, de WM, Postma C, Delis-van Diemen PM, et al. (2010) Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumour Biol 31: 89-96.
12. Distaso A, Abatangelo L, Maglietta R, Creanza TM, Piepoli A, et al. (2008) Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles. Int J Biol Sci 4: 368-378.
13. Maglietta R, Distaso A, Piepoli A, Palumbo O, Carella M, et al. (2010) On the reproducibility of results of pathway analysis in genome-wide expression studies of colorectal cancers. J Biomed Inform 43: 397-406.
14. Heijink DM, Fehrmann RSN, de Vries EGE, Koornstra JJ, Oosterhuis D, et al. (2011) A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer. Oncogene 30: 2026-2036.
15. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
16. Dhillon AS, Hagan S, Rath O, Kolch W, (2007) MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
17. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
18. Danielsen SA, Lind GE, Bjørnslett M, Meling GI, Rognum TO, et al. (2008) Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status. Hum Mutat 29: E252-E262.
19. Yin Y, Shen WH, (2008) PTEN: a new guardian of the genome. Oncogene 27: 5443-5453.
20. Nomoto K, Tomita N, Miyake M, Xhu DB, LoGerfo PR, et al. (1995) Expression of phospholipases gamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol Carcinog 12: 146-152.
21. Fu L, Qin YR, Xie D, Hu L, Kwong DL, et al. (2007) Characterization of a Novel Tumor-Suppressor Gene PLCD1 at 3p22 in Esophageal Squamous Cell Carcinoma. Cancer Res 67: 10720-10726.
22. Kaproth-joslin KA, Li X, Reks SE, Kelley GG, (2008) Phospholipase C D1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity. Biochem J 415: 439-448.
23. Stallings JD, Zeng YX, Narvaez F, Rebecchi MJ, (2008) Phospholipase C D1 Expression Is Linked to Proliferation, DNA Synthesis, and Cyclin E Levels. J Biol Chem 283: 13992-14001.
24. Rebecchi MJ, Raghubir A, Scarlata S, Hartenstine MJ, Brown T, et al. (2009) Expression and function of phospholipase C in breast carcinoma. Adv Enzyme Regul 49: 59-73.
25. Hu XT, Zhang FB, Fan YC, Shu XS, Wong AHY, et al. (2009) Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene 28: 2466-2475.
26. Xiang T, Li L, Fan Y, Jiang Y, Ying Y, et al. (2010) PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biol Ther 10.
27. Sorli SC, Bunney TD, Sugden PH, Paterson HF, Katan M, (2004) Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene 24: 90-100.
28. Wang X, Zbou C, Qiu G, Fan J, Tang H, et al. (2008) Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology 55: 2039-2044.
29. Wang X, Zhou C, Qiu G, Yang Y, Yan D, et al. (2011) Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol [Epub ahead of print].
30. Bunney TD, Baxendale RW, Katan M, (2009) Regulatory links between PLC enzymes and Ras superfamily GTPases: Signalling via PLC epsilon. Adv Enzyme Regul 49: 54-58.
31. Ågesen T, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, et al. (2011) CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early and late onset colorectal cancer. Genes & Immunity [Epub ahead of print].
32. Sveen A, Ågesen T, Nesbakken A, Rognum T, Lothe R, et al. (2011) Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival. Genome Medicine 3: 32.
33. Kleivi K, Teixeira MR, Eknes M, Diep CB, Jakobsen KS, et al. (2004) Genome signatures of colon carcinoma cell lines. Cancer Genet Cytogenet 155: 119-131.
34. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: R80.
35. Hahne F, Huber W, Gentleman R, Falcon S, (2008) Bioconductor case studies. New York Springer Science+Business Media, LCC.
36. Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, et al. (2011) SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene [Epub ahead of print].
37. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, et al. (2008) Hypermethylated MAL gene- a silent marker of early colon tumorigenesis. J Transl Med 6: 1-11.
38. Berg M, Danielsen SA, Ahlquist T, Merok MA, Agesen TH, et al. (2010) DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One 5: e13978asdllkjlskfj.